Skip to content

CO2 Laser + bFGF Gel for Facial Postoperative Scars Study

A Clinical Study of CO2 Laser Conbined with Recombinant Bovine Basic Fibroblast Growth Factor Gel (Beifuxin) for the Treatment of Scars After Facial Tumor Resection)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125086
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-05-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative facial scar

Interventions

Control group:CO2 laser therapy
Research group:CO2 laser combined with Beifuxin gel treatment

Sponsors

Huichang County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.All patients underwent facial mass resection; 2.Early scars occurred 1 to 2 months after the operation; 3.Their ages ranged from 18 to 60 years old; 4.They had no recent history of sun exposure or taking photosensitive drugs; 5.They were not allergic to laser treatment; 6.They had not received any other treatments; 7.Their clinical data were complete; 8.Patients and their families understood the purpose and content of this study and gave written consent to participate in it.

Exclusion criteria

Exclusion criteria: 1.Associated with connective tissue diseases or diseases affecting connective tissue metabolism; 2.Associated with chronic diseases of the heart, lungs, liver, kidneys, etc. 3.Associated with autoimmune diseases; 4.Associated with skin infections around scars; 5.Associated with blood system diseases; 6.Associated with skin malignancies; 7.Pregnant and lactating women; 8.Individuals with a scar-prone constitution; 9.Mental abnormalities; 10.Poor compliance.

Design outcomes

Primary

MeasureTime frame
Recovery status;Scar tissue pain and pruritus;Treatment safety;Scar evaluation;Clinical efficacy;

Secondary

MeasureTime frame
Treatment satisfaction evaluation;

Countries

China

Contacts

Public ContactRaoxia Han

Huichang County People's Hospital

573656696@qq.com+86 797 562 3248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026